Topics

.

Glioblastoma | Treatment | Targeted therapy | Apatinib

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Apatinib

Kuang RZ, Wang J, Wang YC, Tang XP.
Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma.
Clinics (Sao Paulo). 2024 May 10;79:100376. doi: 10.1016/j.clinsp.2024.100376. PMID: 38733690. Observational study. ˍ

Ge J, Li C, Xue F, Zhao C, Kong C, Qi S, Duan Q, Zhang Q, Zhang J.
Alterations of the tumor microenvironment (TME) by exploratory gene expression analysis in recurrent glioblastoma following apatinib in combination with temozolomide.
Biochem Biophys Rep. 2025 Dec 1;45:102364. doi: 10.1016/j.bbrep.2025.102364. PMID: 41438689. Observational study. ˍ

Li J, Hou L, Zhou H, Zhang Z, Wang Y, Zhan X, Wang W, Tian L, Xue X.
Postoperative clinical prognosis in 160 cases of glioblastoma and efficacy of vascular targeted therapy for recurrence.
Neoplasma. 2026 Jun 26:260306N56. doi: 10.4149/neo_2026_260306N56. PMID: 42429148. ˍ